We have advised a fast growing Ducth biotech company in a complex patent and know-how license deal, with regard to proprietary monoclonal antibodies, with one of the largest international pharmaceutical companies worldwide (2014). We have assisted our client in preparing the deal terms, inter alia with the selection and presentation of information, provided an opinion on the validity of patents of third parties and negotiated the contract.
Agreements & Licences
In this case, for a national Dutch scientific institute, we terminated old technology transfer and patent license agreements in the field of DNA technology, that they had concluded with a Ducth start-up company. We formulated new agreements in a clearer, more transparent way, overseeing the negotiation process.
For our client, we negotiated a number of major licence contracts with Asian licensees in the field of vaccine research and development, focusing in particular on product liability, general liability and the enforceability of royalty payments.
Many factors come into place, including compliance with regulations, not just in the sphere of pharmaceutical law but also with regard to financial arrangements with doctors and the transparency of those arrangements, intellectual property, publication of results, liability and scientific integrity.
Many factors come into play, including compliance with regulations, not just in the sphere of pharmaceutical law but also with regard to financial arrangements and the transparency of those arrangements, intellectual property, publication of results, liability and scientific integrity.
Increasingly complex (biotechnology) pharmaceuticals are supported by medical devices and apps offered by the pharmaceutical manufacturer. Their supply to doctors and hospitals and the use of these devices by doctors and patients is heavily regulated: from licences to use mainly web-based technology and liability for the accuracy of data to the protection of patient privacy and regulations on inducements (Code for Pharmaceutical Advertising). We drew up terms and conditions and contracts, so that the programme can be used correctly.